Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendations

Stephen A. Cooper,Paul J. Desjardins,Dennis C. Turk,Robert H. Dworkin,Nathaniel P. Katz,Henrik Kehlet,Jane C. Ballantyne,Laurie B. Burke,Eugene J. Carragee,Penney Cowan,Scott Croll,Raymond A. Dionne,John T. Farrar,Ian Gilron,Debra B. Gordon,Smriti Iyengar,Gary W. Jay,Eija Kalso,Robert D. Kerns,Michael P. McDermott,Srinivasa Naga Raja,Bob A. Rappaport,Christine Rauschkolb,Mike A. Royal,Märta Segerdahl,Joseph W. Stauffer,Knox H. Todd,Geertrui F. Vanhove,Mark S. Wallace,Christine R. West,Richard E. White,Christopher L. Wu

Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendations

2016

AbstractThis article summarizes the results of a meeting convened by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) on key considerations and best practices governing the design of acute pain clinical trials. We discuss the role of early phase clinical trial

Keywords:

Physical therapy
Randomized controlled trial
Research design
Pain assessment
Clinical trial
Assay sensitivity
Analgesic
Medicine
Alternative medicine
acute pain

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations